GBT
Grove Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.42M | Sell |
5,973
-317
| -5% | -$129K | 0.3% | 66 |
|
|
2025
Q1 | $3.13M | Buy |
6,290
+132
| +2% | +$65.7K | 0.42% | 54 |
|
|
2024
Q4 | $3.2M | Buy |
6,158
+66
| +1% | +$34.3K | 0.44% | 48 |
|
|
2024
Q3 | $3.77M | Buy |
6,092
+187
| +3% | +$116K | 0.56% | 41 |
|
|
2024
Q2 | $3.27M | Buy |
5,905
+250
| +4% | +$138K | 0.52% | 40 |
|
|
2024
Q1 | $3.29M | Buy |
5,655
+2,107
| +59% | +$1.22M | 0.55% | 43 |
|
|
2023
Q4 | $1.88M | Buy |
3,548
+70
| +2% | +$37.2K | 0.35% | 57 |
|
|
2023
Q3 | $1.76M | Buy |
3,478
+316
| +10% | +$160K | 0.36% | 57 |
|
|
2023
Q2 | $1.65M | Buy |
3,162
+91
| +3% | +$47.5K | 0.33% | 58 |
|
|
2023
Q1 | $1.77M | Buy |
3,071
+37
| +1% | +$21.3K | 0.37% | 55 |
|
|
2022
Q4 | $1.67M | Buy |
3,034
+1,813
| +148% | +$999K | 0.37% | 58 |
|
|
2022
Q3 | $619K | Hold |
1,221
| – | – | 0.15% | 116 |
|
|
2022
Q2 | $663K | Hold |
1,221
| – | – | 0.16% | 112 |
|
|
2022
Q1 | $721K | Buy |
1,221
+93
| +8% | +$54.9K | 0.14% | 126 |
|
|
2021
Q4 | $753K | Hold |
1,128
| – | – | 0.14% | 124 |
|
|
2021
Q3 | $644K | Hold |
1,128
| – | – | 0.14% | 127 |
|
|
2021
Q2 | $569K | Sell |
1,128
-4
| -0.4% | -$2.02K | 0.12% | 129 |
|
|
2021
Q1 | $517K | Sell |
1,132
-7
| -0.6% | -$3.2K | 0.12% | 135 |
|
|
2020
Q4 | $531K | Buy |
1,139
+159
| +16% | +$74.1K | 0.14% | 125 |
|
|
2020
Q3 | $433K | Buy |
980
+93
| +10% | +$41.1K | 0.13% | 129 |
|
|
2020
Q2 | $321K | Buy |
887
+94
| +12% | +$34K | 0.11% | 146 |
|
|
2020
Q1 | $225K | Sell |
793
-349
| -31% | -$99K | 0.09% | 153 |
|
|
2019
Q4 | $371K | Sell |
1,142
-5
| -0.4% | -$1.62K | 0.11% | 140 |
|
|
2019
Q3 | $334K | Buy |
1,147
+306
| +36% | +$89.1K | 0.11% | 144 |
|
|
2019
Q2 | $247K | Buy |
841
+26
| +3% | +$7.64K | 0.09% | 150 |
|
|
2019
Q1 | $223K | Buy |
+815
| New | +$223K | 0.09% | 153 |
|
|
2018
Q1 | – | Sell |
-755
| Closed | -$143K | – | 433 |
|
|
2017
Q4 | $143K | Sell |
755
-345
| -31% | -$65.3K | 0.06% | 194 |
|
|
2017
Q3 | $208K | Buy |
1,100
+240
| +28% | +$45.4K | 0.1% | 153 |
|
|
2017
Q2 | $150K | Buy |
860
+143
| +20% | +$24.9K | 0.1% | 159 |
|
|
2017
Q1 | $110K | Sell |
717
-950
| -57% | -$146K | 0.09% | 156 |
|
|
2016
Q4 | $235K | Buy |
1,667
+72
| +5% | +$10.2K | 0.18% | 97 |
|
|
2016
Q3 | $254K | Buy |
1,595
+600
| +60% | +$95.5K | 0.22% | 88 |
|
|
2016
Q2 | $147K | Hold |
995
| – | – | 0.13% | 105 |
|
|
2016
Q1 | $141K | Hold |
995
| – | – | 0.13% | 106 |
|
|
2015
Q4 | $141K | Buy |
+995
| New | +$141K | 0.13% | 112 |
|